Huisman MHB, de Jong SW, van Doormaal PTC, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82(10):1165–70. https://doi.org/10.1136/jnnp.2011.244939.

Article  PubMed  Google Scholar 

Chiò A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5–6):310–23. https://doi.org/10.3109/17482960802566824.

Article  PubMed  PubMed Central  Google Scholar 

Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALS. Neurology. 2009;72(22):1948–52. https://doi.org/10.1212/WNL.0b013e3181a8269b.

Article  CAS  PubMed  Google Scholar 

Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66(5):647–53. https://doi.org/10.1212/01.wnl.0000200962.94777.71.

Article  CAS  PubMed  Google Scholar 

Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(11):661–70. https://doi.org/10.1038/nrneurol.2014.184.

Article  PubMed  Google Scholar 

de Boer EMJ, Barritt AW, Elamin M, et al. Facial Onset Sensory and Motor Neuronopathy. Neurol Clin Pract. 2021;11(2):147–57. https://doi.org/10.1212/CPJ.0000000000000834.

Article  PubMed  PubMed Central  Google Scholar 

Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. 2017;18(3–4):153–74. https://doi.org/10.1080/21678421.2016.1267768.

Article  Google Scholar 

Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev Neurol (Paris). 2016;172(1):37–45. https://doi.org/10.1016/j.neurol.2015.11.002.

Article  CAS  PubMed  Google Scholar 

Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(7):740–6. https://doi.org/10.1136/jnnp.2010.235952.

Article  PubMed  Google Scholar 

Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80- ). Published online 2006. https://doi.org/10.1126/science.1134108

Kumar ST, Nazarov S, Porta S, et al. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nat Neurosci. 2023;26(6):983–96. https://doi.org/10.1038/s41593-023-01341-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takeda T, Kitagawa K, Arai K. Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology. 2020;40(1):40–56. https://doi.org/10.1111/neup.12606.

Article  CAS  PubMed  Google Scholar 

Neumann M, Lee EB, Mackenzie IR. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance. In: ; 2021:201–217. https://doi.org/10.1007/978-3-030-51140-1_13

Mishima T, Koga S, Lin WL, et al. Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy. J Neuropathol Exp Neurol. 2017;76(8):676–82. https://doi.org/10.1093/jnen/nlx049.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503–27. https://doi.org/10.1093/brain/awz099.

Article  PubMed  PubMed Central  Google Scholar 

Weihl CC, Temiz P, Miller SE, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008;79(10):1186–9. https://doi.org/10.1136/jnnp.2007.131334.

Article  CAS  PubMed  Google Scholar 

Meneses A, Koga S, O’Leary J, Dickson DW, Bu G, Zhao N. TDP-43 Pathology in Alzheimer’s Disease. Mol Neurodegener. 2021;16(1):84. https://doi.org/10.1186/s13024-021-00503-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakashima-Yasuda H, Uryu K, Robinson J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007;114(3):221–9. https://doi.org/10.1007/s00401-007-0261-2.

Article  CAS  PubMed  Google Scholar 

McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J. TDP-43 pathology in Alzheimer’s disease, dementia with Lewy bodies and ageing. Brain Pathol. 2017;27(4):472–9. https://doi.org/10.1111/bpa.12424.

Article  CAS  PubMed  Google Scholar 

Koga S, Lin WL, Walton RL, Ross OA, Dickson DW. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol. 2018;44(7):707–21. https://doi.org/10.1111/nan.12485.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uryu K, Nakashima-Yasuda H, Forman MS, et al. Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies. J Neuropathol Exp Neurol. 2008;67(6):555–64. https://doi.org/10.1097/NEN.0b013e31817713b5.

Article  CAS  PubMed  Google Scholar 

Riku Y, Iwasaki Y, Ishigaki S, et al. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration. Brain. 2022;145(8):2769–84. https://doi.org/10.1093/brain/awac091.

Article  PubMed  Google Scholar 

Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease. J Neuropathol Exp Neurol. 2008;67(12):1159–65. https://doi.org/10.1097/NEN.0b013e31818e8951.

Article  PubMed  Google Scholar 

Moda F, Ciullini A, Dellarole IL, et al. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception. Front Biosci. 2023;28(10):255. https://doi.org/10.31083/j.fbl2810255.

Article  CAS  Google Scholar 

Wang HY, Wang IF, Bose J, Shen CKJ. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics. 2004;83(1):130–9. https://doi.org/10.1016/S0888-7543(03)00214-3.

Article  CAS  PubMed  Google Scholar 

Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in als and FTD: Disrupted RNA and protein homeostasis. Neuron Published online. 2013. https://doi.org/10.1016/j.neuron.2013.07.033.

Article  Google Scholar 

Ayala YM, Zago P, D’Ambrogio A, et al. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci. 2008;121(22):3778–85. https://doi.org/10.1242/jcs.038950.

Article  CAS  PubMed  Google Scholar 

Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602–11. https://doi.org/10.1016/j.bbrc.2006.10.093.

Article  CAS  PubMed  Google Scholar 

Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VMY. An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun. 2015;6(1):5845. https://doi.org/10.1038/ncomms6845.

Article  CAS  PubMed  Google Scholar 

Tamaki Y, Urushitani M. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD. Int J Mol Sci. 2022;23(20):12508. https://doi.org/10.3390/ijms232012508.

Article  CAS  PubMed  PubMed Central